Protagonist Therapeutics
PTGX
$78.94
Share price
-5.08%
Change (1 day)
69.16%
Change (1 year)
Categories
Protagonist Therapeutics (PTGX) - Cash on Hand
Cash on Hand as of December 2024 : NZ$0.74 Billion
According to Protagonist Therapeutics
's latest financial reports the company has NZ$0.74 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Protagonist Therapeutics - Cash on Hand chart (from 2015 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2024-12-31 | NZ$0.74 B | 37.51% |
| 2023-12-31 | NZ$0.54 B | 44.5% |
| 2022-12-31 | NZ$0.37 B | -21.89% |
| 2021-12-31 | NZ$0.47 B | 12.92% |
| 2020-12-31 | NZ$0.42 B | 114.59% |
| 2019-12-31 | NZ$0.19 B | 2.82% |
| 2018-12-31 | NZ$0.19 B | -5.26% |
| 2017-12-31 | NZ$0.20 B | 80.99% |
| 2016-12-31 | NZ$0.11 B | 543.06% |
| 2015-12-31 | NZ$17.42 M | 46.39% |
| 2014-12-31 | NZ$11.9 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 | NZ$0.45 B | -38.90% | 🇺🇸 USA |